An inhibitor of γ-secretase
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Begacestat

Item No. 27916

Technical Information
Formal Name
5-chloro-N-[(1S)-3,3,3-trifluoro-1-(hydroxymethyl)-2-(trifluoromethyl)propyl]-2-thiophenesulfonamide
CAS Number
769169-27-9
Synonyms
  • GSI-953
Molecular Formula
C9H8ClF6NO3S2
Formula Weight
Purity
≥98%
Formulation
A solid
λmax
262 nm
SMILES
OC[C@@H](NS(C1=CC=C(Cl)S1)(=O)=O)C(C(F)(F)F)C(F)(F)F
InChi Code
InChI=1S/C9H8ClF6NO3S2/c10-5-1-2-6(21-5)22(19,20)17-4(3-18)7(8(11,12)13)9(14,15)16/h1-2,4,7,17-18H,3H2/t4-/m1/s1
InChi Key
PSXOKXJMVRSARX-SCSAIBSYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Product Description

    Begacestat is an inhibitor of γ-secretase that inhibits cleavage of amyloid precursor protein (APP) to amyloid-β (1-40) (Aβ40; Item No. 21617) in vitro (IC50 = 15 nM).1 It is 14-fold selective for γ-secretase over Notch-1. Begacestat (5 mg/kg) reduces brain levels of Aβ40 and Aβ42 (Item No. 20574) in the Tg2576 transgenic mouse model of Alzheimer's disease. It also increases contextual fear conditioning freezing time, indicating reversal of contextual memory deficits, in Tg2576 mice in a dose-dependent manner.2

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Mayer, S.C., Kreft, A.F., Harrison, B., et alDiscovery of begacestat, a Notch-1-sparing γ-secretase inhibitor for the treatment of Alzheimer’s disease. J. Med. Chem. 51(23), 7348-7351 (2008).

    2. Martone, R.L., Zhou, H., Atchison, K., et alBegacestat (GSI-953): A novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein γ-secretase for the treatment of Alzheimer’s disease. J. Pharmacol. Exp. Ther. 331(2), 598-608 (2009).